# WUND Healing BioPharmaceuticals, Inc. — Regulation A 1-A

WUND Healing BioPharmaceuticals, Inc. of Las Vegas, NV filed a Regulation A 1-A with the SEC on 2026-06-29. Aggregate offering: $10 (Tier 2). Industry: Other.

## Offering

- Filed: 2026-06-29
- Form: 1-A
- Accession: 0001477932-26-004058
- Tier: Tier 2
- Total aggregate offering: $10
- Issuer portion: $10
- Price per security: $10.0000
- Securities offered: Equity (common or preferred stock)
- Underwriter: Benjamin Securities, Inc
- Audit status: Audited
- Auditor: Salberg & Company, P.A.
- Jurisdictions: 3 states/territories

## Issuer

- CIK: 0002078607
- Organized in: NV
- Incorporated: 2016
- Address: 8683 W. Sahara Avenue, Las Vegas, NV, 89117
- Phone: 702-800-0030

## Financial snapshot (as filed)

- Total assets: $379K
- Cash & equivalents: $160K
- Total liabilities: $1.2M
- Stockholder equity: $-815K
- Net income: $308K

## More

- [CIK 2078607 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2078607&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/rega/0001477932-26-004058.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.